A detailed history of Hudson Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hudson Capital Management LLC holds 1,988 shares of MRK stock, worth $198,541. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,988
Previous 1,996 0.4%
Holding current value
$198,541
Previous $247,000 8.91%
% of portfolio
0.07%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$111.15 - $128.97 $889 - $1,031
-8 Reduced 0.4%
1,988 $225,000
Q2 2024

Jul 16, 2024

BUY
$123.8 - $132.96 $990 - $1,063
8 Added 0.4%
1,996 $247,000
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $500 - $545
-5 Reduced 0.25%
1,988 $216,000
Q3 2023

Oct 27, 2023

BUY
$102.95 - $114.33 $205,179 - $227,859
1,993 New
1,993 $205,000
Q1 2020

Apr 15, 2020

SELL
$63.36 - $87.82 $285,373 - $395,541
-4,504 Closed
0 $0
Q4 2019

Jan 09, 2020

SELL
$77.58 - $87.54 $33,359 - $37,642
-430 Reduced 8.72%
4,504 $410,000
Q3 2019

Oct 22, 2019

SELL
$76.08 - $82.93 $200,014 - $218,022
-2,629 Reduced 34.76%
4,934 $396,000
Q2 2019

Jul 12, 2019

SELL
$69.84 - $81.59 $84,715 - $98,968
-1,213 Reduced 13.82%
7,563 $634 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $10,089 - $11,507
-145 Reduced 1.63%
8,776 $0
Q4 2018

Jan 16, 2019

BUY
$65.24 - $75.71 $137,982 - $160,126
2,115 Added 31.08%
8,921 $682,000
Q3 2018

Oct 11, 2018

SELL
$57.69 - $67.84 $81,112 - $95,383
-1,406 Reduced 17.12%
6,806 $483,000
Q2 2018

Jul 11, 2018

SELL
$50.83 - $59.72 $19,366 - $22,753
-381 Reduced 4.43%
8,212 $498,000
Q1 2018

May 10, 2018

SELL
$50.96 - $59.23 $25,480 - $29,615
-500 Reduced 5.5%
8,593 $468,000
Q4 2017

Jan 23, 2018

BUY
$51.62 - $61.64 $469,380 - $560,492
9,093
9,093 $512,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hudson Capital Management LLC Portfolio

Follow Hudson Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Capital Management LLC with notifications on news.